This is a preview of subscription content, log in via an institution to check access.
Notes
based on positive galactomannan antigen ELISA results and/or positive polymerase chain reaction assay results for Aspergillus
2012 British pounds
Reference
Barnes R, et al. Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients. Clinical Therapeutics : 17 Apr 2015. Available from: URL: http://doi.org/10.1016/j.clinthera.2015.03.021
Rights and permissions
About this article
Cite this article
Diagnostic-driven strategy cost saving for invasive mycoses. PharmacoEcon Outcomes News 727, 9 (2015). https://doi.org/10.1007/s40274-015-2093-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2093-y